Cargando…
P1031: PRELIMINARY DATA FROM THE PHASE 1/2 STUDY OF TP-3654, AN INVESTIGATIONAL SELECTIVE PIM1 KINASE INHIBITOR, SHOWED CYTOKINE REDUCTION AND CLINICAL RESPONSES IN RELAPSED/REFRACTORY MYELOFIBROSIS
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431443/ http://dx.doi.org/10.1097/01.HS9.0000971020.42358.df |
| _version_ | 1785091204298309632 |
|---|---|
| author | El Chaer, Firas Rein, Lindsay Shimoda, Kazuya Yuda, Junichiro Haque, Tamanna Mccloskey, James Takami, Akiyoshi Fukaya, Masafumi Shirane, Shuichi Kabir, Sujan Mei, Jian LI, Zhonggai Wade, Mark Lebedinsky, Claudia Rampal, Raajit K |
| author_facet | El Chaer, Firas Rein, Lindsay Shimoda, Kazuya Yuda, Junichiro Haque, Tamanna Mccloskey, James Takami, Akiyoshi Fukaya, Masafumi Shirane, Shuichi Kabir, Sujan Mei, Jian LI, Zhonggai Wade, Mark Lebedinsky, Claudia Rampal, Raajit K |
| author_sort | El Chaer, Firas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431443 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104314432023-08-17 P1031: PRELIMINARY DATA FROM THE PHASE 1/2 STUDY OF TP-3654, AN INVESTIGATIONAL SELECTIVE PIM1 KINASE INHIBITOR, SHOWED CYTOKINE REDUCTION AND CLINICAL RESPONSES IN RELAPSED/REFRACTORY MYELOFIBROSIS El Chaer, Firas Rein, Lindsay Shimoda, Kazuya Yuda, Junichiro Haque, Tamanna Mccloskey, James Takami, Akiyoshi Fukaya, Masafumi Shirane, Shuichi Kabir, Sujan Mei, Jian LI, Zhonggai Wade, Mark Lebedinsky, Claudia Rampal, Raajit K Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431443/ http://dx.doi.org/10.1097/01.HS9.0000971020.42358.df Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters El Chaer, Firas Rein, Lindsay Shimoda, Kazuya Yuda, Junichiro Haque, Tamanna Mccloskey, James Takami, Akiyoshi Fukaya, Masafumi Shirane, Shuichi Kabir, Sujan Mei, Jian LI, Zhonggai Wade, Mark Lebedinsky, Claudia Rampal, Raajit K P1031: PRELIMINARY DATA FROM THE PHASE 1/2 STUDY OF TP-3654, AN INVESTIGATIONAL SELECTIVE PIM1 KINASE INHIBITOR, SHOWED CYTOKINE REDUCTION AND CLINICAL RESPONSES IN RELAPSED/REFRACTORY MYELOFIBROSIS |
| title | P1031: PRELIMINARY DATA FROM THE PHASE 1/2 STUDY OF TP-3654, AN INVESTIGATIONAL SELECTIVE PIM1 KINASE INHIBITOR, SHOWED CYTOKINE REDUCTION AND CLINICAL RESPONSES IN RELAPSED/REFRACTORY MYELOFIBROSIS |
| title_full | P1031: PRELIMINARY DATA FROM THE PHASE 1/2 STUDY OF TP-3654, AN INVESTIGATIONAL SELECTIVE PIM1 KINASE INHIBITOR, SHOWED CYTOKINE REDUCTION AND CLINICAL RESPONSES IN RELAPSED/REFRACTORY MYELOFIBROSIS |
| title_fullStr | P1031: PRELIMINARY DATA FROM THE PHASE 1/2 STUDY OF TP-3654, AN INVESTIGATIONAL SELECTIVE PIM1 KINASE INHIBITOR, SHOWED CYTOKINE REDUCTION AND CLINICAL RESPONSES IN RELAPSED/REFRACTORY MYELOFIBROSIS |
| title_full_unstemmed | P1031: PRELIMINARY DATA FROM THE PHASE 1/2 STUDY OF TP-3654, AN INVESTIGATIONAL SELECTIVE PIM1 KINASE INHIBITOR, SHOWED CYTOKINE REDUCTION AND CLINICAL RESPONSES IN RELAPSED/REFRACTORY MYELOFIBROSIS |
| title_short | P1031: PRELIMINARY DATA FROM THE PHASE 1/2 STUDY OF TP-3654, AN INVESTIGATIONAL SELECTIVE PIM1 KINASE INHIBITOR, SHOWED CYTOKINE REDUCTION AND CLINICAL RESPONSES IN RELAPSED/REFRACTORY MYELOFIBROSIS |
| title_sort | p1031: preliminary data from the phase 1/2 study of tp-3654, an investigational selective pim1 kinase inhibitor, showed cytokine reduction and clinical responses in relapsed/refractory myelofibrosis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431443/ http://dx.doi.org/10.1097/01.HS9.0000971020.42358.df |
| work_keys_str_mv | AT elchaerfiras p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis AT reinlindsay p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis AT shimodakazuya p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis AT yudajunichiro p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis AT haquetamanna p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis AT mccloskeyjames p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis AT takamiakiyoshi p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis AT fukayamasafumi p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis AT shiraneshuichi p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis AT kabirsujan p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis AT meijian p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis AT lizhonggai p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis AT wademark p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis AT lebedinskyclaudia p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis AT rampalraajitk p1031preliminarydatafromthephase12studyoftp3654aninvestigationalselectivepim1kinaseinhibitorshowedcytokinereductionandclinicalresponsesinrelapsedrefractorymyelofibrosis |